Published on: 08/27/2026
This news was posted by Oregon Today News
Description

The U.S. Food and Drug Administration has approved a breakthrough drug for the most common form of pancreatic cancer more than six months ahead of schedule, offering what officials described as unprecedented survival rates for patients with limited options.
Other Related News
08/27/2026
Donald Trumps penchant for pageantry may doom his party when the Republicans midterm conve...
08/27/2026
The Willamette Valley is magnificent and Albany is right at the heart Plan your roadtrip t...
08/27/2026
Michael Strahan has become a father for the fifth time welcoming a baby girl with girlfrie...
08/27/2026
ESPN is implementing a major change for its college football broadcasts during the 2026 se...
08/27/2026
